Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
Cytochrome P450 family 2 subfamily A member 6 (CYP2A6) plays a unique role among all P450 enzymes in the liver that are involved in drug metabolism. Compared with other P450 family enzymes, this membrane-bound heme enzyme processes a far smaller range of substrates. Yet among the limited set of substances it can metabolize is an alkaloid with extremely high global consumption, which makes CYP2A6 the core enzyme responsible for eliminating this substance from the body. Every complete catalytic cycle it undergoes follows the conserved catalytic logic shared by all P450 enzymes: at its core lies an iron-carrying heme group anchored by a fixed cysteine thiolate; its partner reductase sequentially delivers electrons to it; the active site is shaped by surrounding helical structures that are precisely sized to screen for small, flat molecules containing nitrogen atoms, completing the full metabolic process. CYP2A6 functions primarily in hepatocytes of the liver. Beyond this main site of action, its presence can also be detected in several barrier tissues, where its measured expression levels are sufficient to support its corresponding physiological roles. Among all human enzymes involved in drug metabolism, its interindividual activity variation is among the largest. This extreme variability is the core driving force behind the academic community's sustained research into CYP2A6. Numerous factors contribute to this variability: gene deletions, base substitutions that completely abolish enzyme activity, and changes in gene copy number combine to create an extremely wide activity span: some individuals almost entirely lose the enzyme's function, with their metabolic activity nearly undetectable, while others have an unusually rapid metabolic turnover rate that far exceeds normal levels.
Fig.1 Schematic of nicotine metabolic pathways showing potential inhibition of CYP2A6-mediated metabolism.1
A handful of research threads keep this enzyme busy:
The CYP2A6 we produce follows iron conditions throughout its generation logic, fully consistent with natural synthesis rules. The full-length CYP2A6 we obtain is developed using a specialized optimized expression system, which preserves the native folding state of the natural molecule throughout the production process. Even the various post-translational modification features added after synthesis are identical to those that form naturally within organisms. For every batch of products shipped, a complete factory release test report is included, and the contents of the report are all verifiable test results: purity data measured via the SDS-PAGE method, and monodispersity data measured via analytical-grade size-exclusion chromatography, which proves that the molecules in the product exist in a uniform single state and will not aggregate into clumps that affect usage. The Membrane Protein Product of CYP2A6 we launch does not have fixed, rigid specifications. If you have specific research requirements, whether you need to adjust any parameters or modify any details, you may put forward your requests. We can specially design, adjust and even modify the product according to your requirements, and meet all kinds of research needs in your laboratory.
Not finding the membrane protein product you need? Contact us to start your one-stop custom service!
Expression level is the core variable that determines the final output of cellular metabolism. If this parameter is ambiguous, subsequent experimental data cannot be clarified at all. Therefore, when we construct cell models for CYP2A6 research, we build all of them in accordance with clear standardized tiers, and never use unstandardized, ambiguous descriptions such as "high expression" to mislead users. Every cell clone undergoes a complete set of characterization tests before being delivered to you: the expression level of CYP2A6 is first quantified and calibrated, its subcellular localization is fully documented, and finally its catalytic activity is verified to be normal. By the time you receive the cell line and prepare to start your own experiments, you will already have a thorough understanding of its metabolic behaviors, and will never encounter a situation where unclear parameters render it unusable after you receive it.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Within the CYP family, the members of the 2A subfamily share particularly close genetic relationships and high sequence similarity. If the antibody clone used for detection cannot distinguish between these closely related members, unintended cross-reactivity will occur. This mismatching often goes undetected in time, and by the time you notice an abnormality, the quantitative detection results will have long been invalidated due to errors. The recombinant antibody portfolio we offer first passes a screening stage to ensure every product can specifically recognize CYP2A6 without confusion with other members of the subfamily; after passing the screening stage, it undergoes three additional rounds of validation, covering the scenarios of quantitative detection of cell lysates, distribution mapping of fixed samples, and imaging-based detection, ensuring stable performance across all commonly used research scenarios. When characterizing each antibody clone, we use sample types that researchers actually use in routine work, and never fill requirements with rare, specialized samples. Furthermore, all production follows clear sequence standards. Even if your research project spans several years, the performance of antibodies purchased from different batches will remain consistently stable, so you will never encounter a situation where the effect of one batch differs from the previous one, which could delay your long-term research progress.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Extending well beyond our standard catalog, we deliver fully customizable discovery and manufacturing solutions meticulously tailored to the sophisticated demands of CYP2A6-targeted research and precompound development:
A brief description of the application, the format envisioned, and any acceptance criteria already in mind is sufficient. Technical details can be refined together from there.
Catalog items cover standard detection or activity workflows well. Custom production earns its place when constructs, formats, or quality attributes step beyond routine specifications. A short consultation is usually enough to decide.
Yes. Custom formats and integrated multi-component engagements are routine, with unified quality frameworks keeping specifications aligned.
All CYP2A6 products and services are provided strictly for preclinical research. They are not designed, validated, or authorized for any use involving human subjects.